Morgan Stanley moved in to support the 100p issue price of Scottish drug firm ProStrakan today after more than three million shares changed hands in the informal grey market. The shares start trading on the London Stock Exchange on Thursday.

The issue price had already been cut by 25% and the bank's stabilisation programme was designed to prevent the price going to a discount.